WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 3, 2007, 27(1):234-244; doi:10.1523/JNEUROSCI.3593-06.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaushal, V.
Right arrow Articles by Schlichter, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaushal, V.
Right arrow Articles by Schlichter, L. C.

 Previous Article  |  Next Article 

Neurobiology of Disease
The Ca2+-Activated K+ Channel KCNN4/KCa3.1 Contributes to Microglia Activation and Nitric Oxide-Dependent Neurodegeneration

Vikas Kaushal,1,2 Paulo D. Koeberle,1 Yimin Wang,1 and Lyanne C. Schlichter1,2

1Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada M5T 2S8, and 2Department of Physiology, University of Toronto, Toronto, Ontario, Canada M5S 1A1

Correspondence should be addressed to Lyanne C. Schlichter, Toronto Western Hospital, MC9-417, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8. Email: schlicht{at}uhnres.utoronto.ca

Brain damage and disease involve activation of microglia and production of potentially neurotoxic molecules, but there are no treatments that effectively target their harmful properties. We present evidence that the small-conductance Ca2+/calmodulin-activated K+ channel KCNN4/ KCa3.1/SK4/IK1 is highly expressed in rat microglia and is a potential therapeutic target for acute brain damage. Using a Transwell cell-culture system that allows separate treatment of the microglia or neurons, we show that activated microglia killed neurons, and this was markedly reduced by treating only the microglia with a selective inhibitor of KCa3.1 channels, triarylmethane-34 (TRAM-34). To assess the role of KCa3.1 channels in microglia activation and key signaling pathways involved, we exploited several fluorescence plate-reader-based assays. KCa3.1 channels contributed to microglia activation, inducible nitric oxide synthase upregulation, production of nitric oxide and peroxynitrite, and to consequent neurotoxicity, protein tyrosine nitration, and caspase 3 activation in the target neurons. Microglia activation involved the signaling pathways p38 mitogen-activated protein kinase (MAPK) and nuclear factor {kappa}B (NF-{kappa}B), which are important for upregulation of numerous proinflammatory molecules, and the KCa3.1 channels were functionally linked to activation of p38 MAPK but not NF-{kappa}B. These in vitro findings translated into in vivo neuroprotection, because we found that degeneration of retinal ganglion cells after optic nerve transection was reduced by intraocular injection of TRAM-34. This study provides evidence that KCa3.1 channels constitute a therapeutic target in the CNS and that inhibiting this K+ channel might benefit acute and chronic neurodegenerative disorders that are caused by or exacerbated by inflammation.

Key words: microglia activation; neurodegeneration; neuroinflammation; Ca2+-activated K+ channel; KCNN4/KCa3.1/IK1/SK4; optic nerve; retinal ganglion cell


Received Aug. 18, 2006; revised Nov. 29, 2006; accepted Nov. 30, 2006.

Correspondence should be addressed to Lyanne C. Schlichter, Toronto Western Hospital, MC9-417, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8. Email: schlicht{at}uhnres.utoronto.ca




This article has been cited by other articles:


Home page
J. Neurosci.Home page
E. Avignone, L. Ulmann, F. Levavasseur, F. Rassendren, and E. Audinat
Status Epilepticus Induces a Particular Microglial Activation State Characterized by Enhanced Purinergic Signaling
J. Neurosci., September 10, 2008; 28(37): 9133 - 9144.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. A. Dwyer, D. E. Earl, and L. Wang
The Utility of a New In Vitro Model of the Stroke Penumbra
J. Neurosci., June 25, 2008; 28(26): 6537 - 6538.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. L. Lee, Y. Hasegawa, T. Shimizu, and Y. Okada
IK1 channel activity contributes to cisplatin sensitivity of human epidermoid cancer cells
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1398 - C1406.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. Kaushal and L. C. Schlichter
Mechanisms of Microglia-Mediated Neurotoxicity in a New Model of the Stroke Penumbra
J. Neurosci., February 27, 2008; 28(9): 2221 - 2230.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Beck, R. Penner, and A. Fleig
Lipopolysaccharide-induced down-regulation of Ca2+ release-activated Ca2+ currents (ICRAC) but not Ca2+-activated TRPM4-like currents (ICAN) in cultured mouse microglial cells
J. Physiol., January 15, 2008; 586(2): 427 - 439.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-